PropertyValue
?:abstract
  • The evaluated SARS-CoV-2 antigen rapid fluorescence immunoassays reliably identified patients within the first 5 days of symptom onset, when respiratory secretions carried high viral loads. This high performance suggests that these tests might play an important role for future PCR-independent strategies to detect early or infective cases.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1101/2020.10.04.20206466
?:externalLink
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Rapid SARS-CoV-2 antigen detection by immunofluorescence - a new tool to detect infectivity
?:type
?:who_covidence_id
  • #20206466

Metadata

Anon_0  
expand all